Physician

Ahmad Mohamad, M.D

According to 2025 Medicare claims, Ahmad Mohamad, M.D (NPI: 1891071007) practices nephrology in the Springfield, IL market, with the plurality of this provider's patient population coming from Sangamon, IL. This provider's primary affiliated billing organization is SPRINGFIELD CLINIC, LLP (NPI: 1780638478; TIN: 370701328) and primary practice location at 62702-3757. Mohamad is affiliated with the Springfield Clinic ACO, LLC (ACO ID: A2587), IRCCO (ACO ID: A2619), AdvantagePoint Health Alliance - Northwest, LLC (ACO ID: A5025), SBL accountable care organization (ACO ID: A5147), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Mohamad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 374 traditional Medicare patients, billed 1,045 HCPCS/CPT codes, and received $90,927 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 913 prescription claims across 177 beneficiaries totaling $137,822 in drug costs, led by Jardiance (Empagliflozin). DME data shows 11 claims. Open Payments data shows 1 records totaling $27. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $87,129 and ending at $90,927. Concurrently, Part D prescription costs have fallen sharply in recent years, from $209,781 to $137,822. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $4,453 to $1,331.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	491	1,570	$87,129
2016	512	2,417	$119,830
2017	442	1,899	$90,328
2018	371	1,643	$54,936
2019	421	2,025	$72,436
2020	256	791	$13,209
2021	N/R	N/R	N/R
2022	160	433	$35,454
2023	358	1,178	$107,424
2024	374	1,045	$90,927

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	562	4,538	$209,781
2016	752	12,145	$688,651
2017	859	18,004	$1,067,531
2018	766	16,933	$1,046,420
2019	866	16,364	$1,055,104
2020	680	10,644	$668,005
2021	252	1,203	$73,353
2022	37	162	$9,871
2023	143	563	$116,155
2024	177	913	$137,822

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	14	92	$4,123
2016	71	446	$12,045
2017	93	622	$18,645
2018	80	609	$17,547
2019	69	491	$11,540
2020	19	199	$6,750
2021	N/R	56	$2,199
2022	N/R	12	$323
2023	N/R	N/R	N/R
2024	N/R	11	$487

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	52	58	$104
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	98	220	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	120	188	$82
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	63	111	$60
36415	Insertion of needle into vein for collection of blood sample	69	110	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	64	2,460	$48,255
Farxiga	Dapagliflozin Propanediol	56	2,039	$38,496
Prosol	Parenteral Amino Acid 20% No.1	24	168	$8,246
Sevelamer Carbonate	Sevelamer Carbonate	30	1,095	$4,403
Tamsulosin Hcl	Tamsulosin Hcl	65	3,330	$547

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0630	Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)	Y	N/R	11	$487

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$27	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Mohamad, M.D?

Tedicare shows public-source Medicare data for Ahmad Mohamad, M.D (NPI 1891071007), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Mohamad, M.D have ACO affiliation data?

Ahmad Mohamad, M.D is shown with ACO affiliation data for Springfield Clinic ACO, LLC (MSSP, ACO ID A2587), IRCCO (MSSP, ACO ID A2619), AdvantagePoint Health Alliance - Northwest, LLC (MSSP, ACO ID A5025), SBL accountable care organization (MSSP, ACO ID A5147), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Ahmad Mohamad, M.D?

Ahmad Mohamad, M.D is linked to SPRINGFIELD CLINIC, LLP (billing NPI 1780638478) in the available physician profile data.

Does Ahmad Mohamad, M.D have Open Payments data?

Ahmad Mohamad, M.D has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.